Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Cytarabine
- Drug class
- Nucleoside Metabolic Inhibitor
- Form
- Injectable
- Strength
- Cytarabine 100MG/VIAL · Cytarabine 1GM/VIAL · Cytarabine 2GM/VIAL · Cytarabine 500MG/VIAL
- Type
- Prescription (Rx)
- Brand or generic
- Generic
- May treat
- leukemia, lymphoma, meningeal neoplasms
- Manufacturer
- Teva
- FDA application
- ANDA075206
- Availability
- Discontinued (per FDA)
Drug class
How this class works, per Gemcitabine — LiverTox, NCBI Bookshelf (NIH).
May treat (source: NIH RxClass)
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Cytosar-U treat?
- Cytosar-U (Cytarabine) may be used to treat leukemia, lymphoma, meningeal neoplasms, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How does Cytosar-U work?
- Cytosar-U is a nucleoside metabolic inhibitor. Nucleoside metabolic inhibitors are fake DNA building blocks that fast-dividing cancer cells mistake for the real thing. Once inside, they get incorporated into the cell's DNA and also block enzymes such as ribonucleotide reductase, which together halt DNA copying and cause the cancer cell to die.
- How is Cytosar-U rated?
- pharmaranks gives Cytosar-U a composite score of 2.8 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Cytosar-U?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Cytosar-U. To pay less, Cytosar-U is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Cytosar-U?
- Cytosar-U is marketed by Teva. You can see Teva's full profile, rating, and other products on pharmaranks.
- Is Cytosar-U a brand-name or generic drug?
- Cytosar-U is a generic medication; its active ingredient is Cytarabine. Generics contain the same active ingredient as the brand-name original and are usually lower cost.
- Is Cytosar-U available over the counter?
- No. Cytosar-U is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Cytosar-U come in?
- Cytosar-U is currently marketed as injectable, per the FDA's National Drug Code Directory.
- What class of drug is Cytosar-U?
- Cytosar-U is classified as nucleoside metabolic inhibitor, per the FDA's Established Pharmacologic Class.
- Is Cytosar-U FDA-registered?
- Cytosar-U is on record with the U.S. FDA under application number ANDA075206. You can verify this on its official FDA label.
- Has Cytosar-U been recalled by the FDA?
- Cytosar-U has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Cytosar-U safe?
- There's no single safe-or-not verdict. pharmaranks gives Cytosar-U a recall-safety score of 56/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
cytarabine
Cytarabine
tolak
Fluorouracil
azacitidine
Azacitidine
arranon
Nelarabine
capecitabine
Capecitabine
decitabine
Decitabine
Compare Cytosar-U head-to-head
More nucleoside metabolic inhibitor drugs
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
cytosar-u
56/100